InvestorsHub Logo
Post# of 252642
Next 10
Followers 1
Posts 204
Boards Moderated 0
Alias Born 02/28/2006

Re: None

Saturday, 09/10/2011 7:21:45 PM

Saturday, September 10, 2011 7:21:45 PM

Post# of 252642
Looks like BMO must have a new biotech analyst. The link below has a short summary of his opinion on the below companies.

http://www.bmonesbittburns.com/IA/IAHomepage/NewsToBrowser.asp?IA_ID=NCHOWBAY&LANGUAGE=EN&NEWS_ID=426&VERSION=305

Initiating Coverage
Chefs’ Warehouse: A Long Runway for Growth K. Short 8
Amgen: Initiating Coverage With Outperform Rating J. Birchenough 12
Ariad Pharmaceuticals: Initiating Coverage With Outperform Rating J. Birchenough 14
Cardiome Pharmaceuticals: Initiating Coverage at Outperform J. Birchenough 16
Celgene: Initiating Coverage With Outperform and $90 Price Target J. Birchenough 18
Halozyme Therapeutics: Initiating Coverage With Outperform Rating J. Birchenough 20
Human Genome Sciences: Initiating Coverage With Outperform Rating J. Birchenough 22
Isis Pharmaceuticals: Initiating With Outperform Rating and $15 Target J. Birchenough 24
Regeneron Pharmaceuticals: Initiating Coverage With Outperform Rating J. Birchenough 26
Rigel Pharmaceuticals: Initiating With Outperform Rating and $17 Target J. Birchenough 28
United Therapeutics: Initiating Coverage With Outperform and $54 Price Target J. Birchenough 30
Amylin Pharmaceuticals: Initiating Coverage With Market Perform J. Birchenough 32
Arena Pharmaceuticals: Initiating Coverage With Market Perform J. Birchenough 34
Array BioPharma: Initiating With Market Perform Rating J. Birchenough 36
Gilead Sciences: Initiating Coverage With Market Perform Rating J. Birchenough 38
NPS Pharmaceuticals: Initiating Coverage With Market Perform Rating J. Birchenough 40
Onyx Pharmaceuticals: Initiating Coverage With Market Perform Rating and $34 Target J. Birchenough 42
Synta Pharmaceuticals: Initiating Coverage With Market Perform Rating J. Birchenough 44
ZIOPHARM Oncology: Initiating Coverage With Market Perform J. Birchenough 46
Biogen Idec: Initiating Coverage at Underperform With $74 Price Target J. Birchenough 48
Genomic Health: Initiating Coverage at Underperform J. Birchenough 50
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.